Trinity Biotech Files Routine 6-K Report
Ticker: TRIB · Form: 6-K · Filed: Feb 6, 2025 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Feb 6, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, routine-report
TL;DR
Trinity Biotech filed a standard 6-K, no new news.
AI Summary
Trinity Biotech plc filed a Form 6-K on February 6, 2025, to report for the month of February 2025. The company, based in Dublin, Ireland, is a foreign private issuer and files annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Trinity Biotech plc is fulfilling its regular reporting obligations as a foreign private issuer with the SEC. It does not contain new material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new material information or disclose any significant changes in the company's operations or financial status.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- IDA Business Park, Bray, Co. Wicklow, Ireland (location) — Principal Executive Office
- Dublin, Ireland (location) — Company Headquarters
- February 2025 (date) — Reporting Period
- February 6, 2025 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, filed for the month of February 2025.
What is the company's principal executive office address?
The company's principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Does Trinity Biotech plc file annual reports under Form 20-F or Form 40-F?
Trinity Biotech plc files annual reports under cover of Form 20-F.
What is the filing date of this report?
This report was filed on February 6, 2025.
What is the Standard Industrial Classification (SIC) code for Trinity Biotech plc?
The SIC code for Trinity Biotech plc is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Stats: 323 words · 1 min read · ~1 pages · Grade level 15 · Accepted 2025-02-06 09:00:33
Filing Documents
- zk2532668.htm (6-K) — 13KB
- exhibit_99-1.htm (EX-99.1) — 16KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-25-000349.txt ( ) — 155KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Louise Tallon Louise Tallon Chief Financial Officer Date: February 6, 2025